In the BioHarmony Drug Report Database

"Preview" Icon

Somapacitan

Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.

 

Trade Name

 

Sogroya
 

Common Name

 

somapacitan
 

ChEMBL ID

 

CHEMBL3707290
 

Indication

 

growth
 

Drug Class

 

Growth hormone derivatives

Image (chem structure or protein)

Somapacitan structure rendering